Chinese Buying Coronavirus Drugs for Pet Infections
In an unexpected turn of events, pharmaceutical companies have reported a surge in orders for certain COVID-19 treatments, not from hospitals, but from pet owners in China. The reason? Chinese pet owners are using these drugs to treat their cats for feline coronavirus infections.
Feline coronavirus (FCoV) is a common virus in cats, but it typically does not cause serious illness. However, a rare but life-threatening strain, known as feline infectious peritonitis (FIP), has left pet owners desperate for treatment options. With the rise of COVID-19, two drugs in particular have gained attention: remdesivir and dexamethasone.
Remdesivir, an antiviral medication developed by Gilead Sciences, has shown promising results in treating COVID-19. It has also been observed to help some cats with FIP, leading Chinese pet owners to import it from overseas. Dexamethasone, a steroid used to reduce inflammation in COVID-19 patients, is also being explored as a potential treatment for FIP due to its anti-inflammatory properties.
While the use of these drugs in cats is not yet widely accepted or approved by veterinarians, anecdotal evidence from pet owners has sparked interest. However, veterinary experts caution against self-medicating pets. "While these drugs might help in some cases, their efficacy and safety in cats are not yet proven," warns Dr. Liang, a veterinarian at a prominent animal hospital in Shanghai.
The unusual demand for COVID-19 drugs by pet owners has pharmaceutical companies reevaluating their production and supply chains. The spike in orders has even led some companies to temporarily halt sales to hospitals to meet the unexpected demand.
This unique development highlights the lengths to which pet owners will go to protect their furry friends, as well as the intersection of human and animal healthcare. As research into these drugs continues, pet owners and veterinarians alike await concrete evidence of their safety and effectiveness in treating FIP.
Worth a look